why does tirzepatide burn when injecting Injection Site Red and Itchy: Causes and Solutions Tirzepatide activates both GLP‑1 and
Description
Tirzepatide is sold under the brand name Mounjaro and it is a prescription medication
RAGE (Receptor for Advanced Glycation End Products): a Central Player in the Inflammatory Response

TL;DR: People lose different amounts of weight on GLP-1 medications On average, women lose a higher percentage of body weight on GLP-1s Weight loss was similar across age groups, race/ethnicity, and baseline weight Some genetic variants are associated with more weight loss, but the effects are relatively small

Importantly, the study included a diverse group of participantsnearly 20% identified as Black and about 26% as Hispanic or Latinomaking the results more broadly applicable to people in the U.S

Data availability statement The data is available from the corresponding author upon reasonable request

Clinical trials show that tirzepatide produces greater reductions in HbA1c and body weight than the best available GLP-1 receptor agonists